Immune Design Reports Second Quarter 2015 Financial Results
Go back to Immune Design Reports Second Quarter 2015 Financial Results| (NASDAQ: IMDZ) | Delayed: 5.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.85 | 52 Week High | $23.55 | |||
| Open | $17.64 | 52 Week Low | $4.50 | |||
| Day High | $5.85 | P/E | N/A | |||
| Day Low | $5.85 | EPS | $0.00 | |||
| Volume | 192,912 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 128.09 +4.48 (3.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.61 | 52 Week High | $65.46 | |||
| Open | $124.33 | 52 Week Low | $47.97 | |||
| Day High | $128.93 | P/E | 87.14 | |||
| Day Low | $124.00 | EPS | $1.47 | |||
| Volume | 5,454,753 | |||||
